Pilot Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer
This is a pilot, prospective, interventional, monocentric study designed to evaluate, in a real-life situation, adherence to tamoxifen treatment as a function of the taking of alternative and complementary therapies in patients with localized hormone-dependent breast cancer. 200 patients will be included in the study. Each patient will be followed for one day.
• Age ≥ 18 years at entry into the study.
• Patient treated for hormone-dependent localized breast cancer requiring adjuvant Hormonal Therapy (HT) with tamoxifen.
• Patients treated with tamoxifen for a maximum of 1 to 3 years.
• Patient affiliated with a Social Security system in France.
• Patients who signed informed consent prior to inclusion in the study and prior to any specific study procedures.